-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Nabriva Therapeutics plc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2016 to Q2 2023.
- Nabriva Therapeutics plc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2023 was 3.23M shares, a 27.7% increase year-over-year.
- Nabriva Therapeutics plc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 2.68M shares, a 54.7% increase from 2021.
- Nabriva Therapeutics plc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 1.73M shares, a 237% increase from 2020.
- Nabriva Therapeutics plc annual Weighted Average Number of Shares Outstanding, Diluted for 2020 was 514K shares, a 93.1% decline from 2019.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)